Three more western pharmaceutical companies have been drawn into widening Chinese probes into pricing and marketing practices in the drug industry, with Lundbeck and Novo Nordisk reporting recent inquiries from the authorities, and Sanofi investigating allegations made by a whistleblower.
隨著中國擴(kuò)大對醫(yī)藥行業(yè)定價(jià)和營銷行為的調(diào)查，又有3家西方制藥公司成為調(diào)查對象。靈北(Lundbeck)和諾和諾德(Novo Nordisk)稱近期受到有關(guān)部門詢問，而賽諾菲(Sanofi)對一名舉報(bào)者的指控展開調(diào)查。
您已閱讀14%（397字），剩余86%（2392字）包含更多重要信息，訂閱以繼續(xù)探索完整內(nèi)容，并享受更多專屬服務(wù)。